February 2025's Promising Penny Stocks To Consider

Global markets have faced a turbulent start to 2025, with U.S. stocks experiencing volatility due to AI competition fears and tariff risks, while European indices reached new highs following positive earnings and ECB rate cuts. In such fluctuating conditions, investors might find opportunities in penny stocks—smaller or newer companies that can offer unique growth potential despite their often overlooked status. Although the term "penny stocks" may seem outdated, these investments can still present compelling opportunities when backed by strong financials, offering a mix of affordability and potential for long-term success.

Top 10 Penny Stocks

Name	Share Price	Market Cap	Financial Health Rating
Bosideng International Holdings (SEHK:3998)	HK$3.69	HK$42.39B	★★★★★★
DXN Holdings Bhd (KLSE:DXN)	MYR0.525	MYR2.61B	★★★★★★
Datasonic Group Berhad (KLSE:DSONIC)	MYR0.395	MYR1.1B	★★★★★★
Polar Capital Holdings (AIM:POLR)	£4.89	£482.95M	★★★★★★
MGB Berhad (KLSE:MGB)	MYR0.70	MYR414.16M	★★★★★★
Hil Industries Berhad (KLSE:HIL)	MYR0.88	MYR285.47M	★★★★★★
Tristel (AIM:TSTL)	£3.65	£178.85M	★★★★★★
Lever Style (SEHK:1346)	HK$1.10	HK$698.27M	★★★★★★
Embark Early Education (ASX:EVO)	A$0.79	A$144.95M	★★★★☆☆
China Lilang (SEHK:1234)	HK$3.92	HK$4.69B	★★★★★☆

Click here to see the full list of 5,722 stocks from our Penny Stocks screener.

We'll examine a selection from our screener results.

Groupe Tera (ENXTPA:ALGTR)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Groupe Tera SA, along with its subsidiaries, specializes in the analysis of chemical air pollutants both in France and internationally, with a market cap of €14.30 million.

Operations: The company generates €12.76 million in revenue from its operations in France.

Market Cap: €14.3M

Groupe Tera SA, with a market cap of €14.30 million, has shown improvement in its financial stability despite being unprofitable. Its short-term assets exceed both short and long-term liabilities, indicating solid liquidity management. The company reported half-year sales of €6.47 million, slightly down from the previous year but significantly reduced its net loss to €0.003 million from €0.943 million. While trading at 66% below estimated fair value suggests potential upside, high volatility and a negative return on equity highlight ongoing risks for investors in this space. However, it maintains a cash runway exceeding three years due to positive free cash flow growth.

• Navigate through the intricacies of Groupe Tera with our comprehensive balance sheet health report here.
• Review our historical performance report to gain insights into Groupe Tera's track record.

ikeGPS Group (NZSE:IKE)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: ikeGPS Group Limited designs, sells, and delivers solutions for the collection, analysis, and management of distribution assets for electric utilities and communications companies in the United States, with a market cap of NZ$101.27 million.

Operations: The company's revenue is derived from three segments: Platform Transactions (NZ$7.56 million), Platform Subscriptions (NZ$12.15 million), and Hardware and Other Services (NZ$3.05 million).

Market Cap: NZ$101.27M

ikeGPS Group Limited, with a market cap of NZ$101.27 million, is navigating challenges typical for companies in its sector. Despite being unprofitable and having a negative return on equity of -112.96%, it benefits from being debt-free and having short-term assets exceeding liabilities, which underscores its liquidity strength. Revenue growth is projected at 26.26% annually, although past losses have increased by 21.5% per year over five years. The company has a cash runway for 1.7 years if free cash flow trends continue but faces risks from recent insider selling and an inexperienced management team averaging 1.6 years in tenure.

• Click to explore a detailed breakdown of our findings in ikeGPS Group's financial health report.
• Gain insights into ikeGPS Group's outlook and expected performance with our report on the company's earnings estimates.

Scales (NZSE:SCL)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Scales Corporation Limited is involved in the manufacture and trading of food ingredients across New Zealand, Asia, Europe, North America, and other international markets, with a market cap of NZ$581.46 million.

Operations: The company generates revenue primarily from three segments: Global Proteins (NZ$289.15 million), Horticulture (NZ$221.86 million), and Logistics (NZ$94.55 million).

Market Cap: NZ$581.46M

Scales Corporation Limited, with a market cap of NZ$581.46 million, has recently turned profitable, marking a significant shift in its financial trajectory. The company's debt is well-managed, with interest payments comfortably covered by EBIT and operating cash flow adequately covering debt levels. However, the increase in the debt-to-equity ratio over the past five years warrants attention. Earnings have declined by 25.9% annually over five years but are forecast to grow at 16.19% per year moving forward. Despite a low return on equity of 12%, Scales trades significantly below its estimated fair value and maintains strong liquidity with short-term assets exceeding liabilities.

• Take a closer look at Scales' potential here in our financial health report.
• Understand Scales' earnings outlook by examining our growth report.

Taking Advantage

• Gain an insight into the universe of 5,722 Penny Stocks by clicking here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Looking For Alternative Opportunities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com